Role of mucosal mast cells in visceral hypersensitivity in a rat model of irritable bowel syndrome.

Jun-Ho La, Tae Wan Kim, Tae Sik Sung, Hyun Ju Kim, Jeom Yong Kim, Il Suk Yang

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

The involvement of mucosal mast cells (MMC) in the pathophysiology of irritable bowel syndrome (IBS) is still controversial. We aimed to re-evaluate the role of MMC in visceral hypersensitivity associated with IBS using a rat IBS model that develops the IBS symptom after a subsidence of acetic acid-induced colitis. No significant difference in the number of MMC was observed between normal rat colon and IBS rat colon. (61.7 +/- 2.9/mm(2) in normal vs. 88.7 +/- 13.3/mm(2) in IBS, p > 0.29). However, the degranulation rate of MMC was significantly higher in IBS rat colon (49.5 +/- 2.4% in normal vs. 68.8 +/- 3.4% in IBS, p <0.05). Pretreatment of a mast cell stabilizer, doxantrazole (5 mg/kg, i.p.), reduced the degranulation rate of MMC and significantly attenuated visceral hypersensitivity to rectal distension in IBS rat, whereas it had no effect on the visceral sensory responses in normal rat. These results suggest that, although the number of MMC is not significantly changed in IBS rat colon, the higher degranulation rate of MMC is responsible for visceral hypersensitivity in this model IBS.

Original languageEnglish (US)
Pages (from-to)319-324
Number of pages6
JournalJournal of Veterinary Science
Volume5
Issue number4
StatePublished - Dec 2004
Externally publishedYes

Fingerprint

Irritable Bowel Syndrome
mast cells
Mast Cells
hypersensitivity
Hypersensitivity
animal models
rats
colon
Colon
irritable bowel syndrome
subsidence
colitis
Colitis
pathophysiology
Acetic Acid
signs and symptoms (animals and humans)
acetic acid
pretreatment

ASJC Scopus subject areas

  • veterinary(all)

Cite this

La, J-H., Kim, T. W., Sung, T. S., Kim, H. J., Kim, J. Y., & Yang, I. S. (2004). Role of mucosal mast cells in visceral hypersensitivity in a rat model of irritable bowel syndrome. Journal of Veterinary Science, 5(4), 319-324.

Role of mucosal mast cells in visceral hypersensitivity in a rat model of irritable bowel syndrome. / La, Jun-Ho; Kim, Tae Wan; Sung, Tae Sik; Kim, Hyun Ju; Kim, Jeom Yong; Yang, Il Suk.

In: Journal of Veterinary Science, Vol. 5, No. 4, 12.2004, p. 319-324.

Research output: Contribution to journalArticle

La, Jun-Ho ; Kim, Tae Wan ; Sung, Tae Sik ; Kim, Hyun Ju ; Kim, Jeom Yong ; Yang, Il Suk. / Role of mucosal mast cells in visceral hypersensitivity in a rat model of irritable bowel syndrome. In: Journal of Veterinary Science. 2004 ; Vol. 5, No. 4. pp. 319-324.
@article{4c997162462f4a24bea0ef6c897702d5,
title = "Role of mucosal mast cells in visceral hypersensitivity in a rat model of irritable bowel syndrome.",
abstract = "The involvement of mucosal mast cells (MMC) in the pathophysiology of irritable bowel syndrome (IBS) is still controversial. We aimed to re-evaluate the role of MMC in visceral hypersensitivity associated with IBS using a rat IBS model that develops the IBS symptom after a subsidence of acetic acid-induced colitis. No significant difference in the number of MMC was observed between normal rat colon and IBS rat colon. (61.7 +/- 2.9/mm(2) in normal vs. 88.7 +/- 13.3/mm(2) in IBS, p > 0.29). However, the degranulation rate of MMC was significantly higher in IBS rat colon (49.5 +/- 2.4{\%} in normal vs. 68.8 +/- 3.4{\%} in IBS, p <0.05). Pretreatment of a mast cell stabilizer, doxantrazole (5 mg/kg, i.p.), reduced the degranulation rate of MMC and significantly attenuated visceral hypersensitivity to rectal distension in IBS rat, whereas it had no effect on the visceral sensory responses in normal rat. These results suggest that, although the number of MMC is not significantly changed in IBS rat colon, the higher degranulation rate of MMC is responsible for visceral hypersensitivity in this model IBS.",
author = "Jun-Ho La and Kim, {Tae Wan} and Sung, {Tae Sik} and Kim, {Hyun Ju} and Kim, {Jeom Yong} and Yang, {Il Suk}",
year = "2004",
month = "12",
language = "English (US)",
volume = "5",
pages = "319--324",
journal = "Journal of Veterinary Science",
issn = "1229-845X",
publisher = "Korean Society of Veterinary Science",
number = "4",

}

TY - JOUR

T1 - Role of mucosal mast cells in visceral hypersensitivity in a rat model of irritable bowel syndrome.

AU - La, Jun-Ho

AU - Kim, Tae Wan

AU - Sung, Tae Sik

AU - Kim, Hyun Ju

AU - Kim, Jeom Yong

AU - Yang, Il Suk

PY - 2004/12

Y1 - 2004/12

N2 - The involvement of mucosal mast cells (MMC) in the pathophysiology of irritable bowel syndrome (IBS) is still controversial. We aimed to re-evaluate the role of MMC in visceral hypersensitivity associated with IBS using a rat IBS model that develops the IBS symptom after a subsidence of acetic acid-induced colitis. No significant difference in the number of MMC was observed between normal rat colon and IBS rat colon. (61.7 +/- 2.9/mm(2) in normal vs. 88.7 +/- 13.3/mm(2) in IBS, p > 0.29). However, the degranulation rate of MMC was significantly higher in IBS rat colon (49.5 +/- 2.4% in normal vs. 68.8 +/- 3.4% in IBS, p <0.05). Pretreatment of a mast cell stabilizer, doxantrazole (5 mg/kg, i.p.), reduced the degranulation rate of MMC and significantly attenuated visceral hypersensitivity to rectal distension in IBS rat, whereas it had no effect on the visceral sensory responses in normal rat. These results suggest that, although the number of MMC is not significantly changed in IBS rat colon, the higher degranulation rate of MMC is responsible for visceral hypersensitivity in this model IBS.

AB - The involvement of mucosal mast cells (MMC) in the pathophysiology of irritable bowel syndrome (IBS) is still controversial. We aimed to re-evaluate the role of MMC in visceral hypersensitivity associated with IBS using a rat IBS model that develops the IBS symptom after a subsidence of acetic acid-induced colitis. No significant difference in the number of MMC was observed between normal rat colon and IBS rat colon. (61.7 +/- 2.9/mm(2) in normal vs. 88.7 +/- 13.3/mm(2) in IBS, p > 0.29). However, the degranulation rate of MMC was significantly higher in IBS rat colon (49.5 +/- 2.4% in normal vs. 68.8 +/- 3.4% in IBS, p <0.05). Pretreatment of a mast cell stabilizer, doxantrazole (5 mg/kg, i.p.), reduced the degranulation rate of MMC and significantly attenuated visceral hypersensitivity to rectal distension in IBS rat, whereas it had no effect on the visceral sensory responses in normal rat. These results suggest that, although the number of MMC is not significantly changed in IBS rat colon, the higher degranulation rate of MMC is responsible for visceral hypersensitivity in this model IBS.

UR - http://www.scopus.com/inward/record.url?scp=16644372725&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16644372725&partnerID=8YFLogxK

M3 - Article

VL - 5

SP - 319

EP - 324

JO - Journal of Veterinary Science

JF - Journal of Veterinary Science

SN - 1229-845X

IS - 4

ER -